Aimei Health Technology Co., Ltd

NASDAQ:AFJK

Shell Companies

Financial Services
$11.96 -10.76%

-$3.66 today

Market cap
$73.22M
Beta
0.23
P/E (TTM)
34.3
EPS (TTM)
$0.88
52W Low $6.75High $130.37

Volume 0.13M

Average 0.02M

AFJK Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Aimei Health Technology Co., LtdNASDAQ: AFJK

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow turns positive

Q1 FY2026 financing cash flow was $158.86K, compared with -$30.58M a year earlier. Trailing-twelve-month financing cash flow was -$32.3M.

Context

  • Financing cash flow increased in 0 of the last 2 fiscal years.
  • FY2025 was the lowest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near $158.86K or moves back toward the trailing-twelve-month quarterly average of -$8.07M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$158.86K+100.5% QoQ
Last fiscal yearDec 2025
-$63.04M-15960.0% YoY
LTMMar 2026
-$32.3M+7.0% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+100.5%——
1 year-15960.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(63.04M) USD
Year-over-year change
-15960.0%

Financing Cash Flow vs competitors

How AFJK compares with its peers on the latest reported figures

  • AFJK's LTM Mar 2026 financing cash flow of $32.3M is the 6th largest of the 8 companies compared; the peer median is $58.26M.
  • Its year-over-year change of +7.0% is the 2nd highest of 4, against a peer median of -77.4%.
AFJK Competitors Peer median
Financing Cash Flow for AFJK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KOYNCSLM Digital Asset Acquisition Corp III Class A Ordinary SharesFY2025$233.88M ———
ORIQUOrigin Investment Corp I UnitsFY2025$71.54M ———
RIBBRibbon Acquisition CorpLTM Mar 2026$65.67M ———
UYSCUY Scuti Acquisition Corp.LTM Dec 2025$58.26M ———
CPBICentral Plains Bancshares, Inc. Common StockLTM Dec 2025$44.94M +67.8%+4.1%151.4%
AFJKAimei Health Technology Co., LtdLTM Mar 2026$32.3M +7.0%——
EURKEureka Acquisition Corp Class A Ordinary ShareLTM Mar 2026$27.55M -147.2%——
BAYABayview Acquisition Corp Class A Ordinary SharesLTM Mar 2026$5.18M -77.4%——
Peer median (excluding AFJK) $58.26M-77.4%+4.1%151.4%

Competitors are the stored peer set for AFJK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD

Aimei Health Technology Co., Ltd

NASDAQ:AFJK

Intrinsic Alpha fair value

Locked

Current Price

$11.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.